(Q33330493)

English

Phase I evaluation of ISIS 3521, an antisense oligodeoxynucleotide to protein kinase C-alpha, in patients with advanced cancer

scientific article

Statements

Phase I evaluation of ISIS 3521, an antisense oligodeoxynucleotide to protein kinase C-alpha, in patients with advanced cancer (English)
0 references
1 November 1999
3586-3595

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit